🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Temozolomide - Medicines in Ireland

31 authorised products containing Temozolomide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 31 authorised medicines
MedicineActive substanceLicence holderStatus
Temodal 2.5 mg/ml powder for solution for infusion
EU/1/98/096/023
Temozolomide Merck Sharp & Dohme BV
Temomedac 100 mg hard capsules
EU/1/09/605/5-6
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 140 mg hard capsules
EU/1/09/605/7-8
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 180 mg hard capsules
EU/1/09/605/9-10
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 20 mg hard capsules
EU/1/09/605/3-4
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 250 mg hard capsules
EU/1/09/605/11-12
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 5 mg hard capsules
EU/1/09/605/1-2
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temozolomide Accord 100 mg hard capsules
EU/1/10/615/009-010
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 140 mg hard capsules
EU/1/10/615/013-014
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 180 mg hard capsules
EU/1/10/615/017-018
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 20 mg hard capsules
EU/1/10/615/005-006
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 250 mg hard capsules
EU/1/10/615/021-022
Temozolomide Accord Healthcare S.L.U.
Temozolomide Accord 5 mg hard capsules
EU/1/10/615/001-002
Temozolomide Accord Healthcare S.L.U.
Temozolomide Clonmel 100mg hard capsules
PA0126/188/003
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 140mg hard capsules
PA0126/188/004
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 180 mg hard capsules
PA0126/188/005
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 20 mg hard capsules
PA0126/188/002
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 250 mg hard capsules
PA0126/188/006
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 5mg hard capsules
PA0126/188/001
Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide FAIR-MED 100 mg hard capsules
PA23270/002/003
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 140 mg hard capsules
PA23270/002/004
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 180 mg hard capsules
PA23270/002/005
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 20 mg hard capsules
PA23270/002/002
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 250 mg hard capsules
PA23270/002/006
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 5 mg hard capsules
PA23270/002/001
Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide Teva 100 mg hard capsules
EU/1/09/606/005-006
Temozolomide Teva B.V.
Temozolomide Teva 140 mg hard capsules
EU/1/09/606/007-008
Temozolomide Teva B.V.
Temozolomide Teva 180 mg hard capsules
EU/1/09/606/009-010
Temozolomide Teva B.V.
Temozolomide Teva 20 mg hard capsules
EU/1/09/606/003-004
Temozolomide Teva B.V.
Temozolomide Teva 250 mg hard capsules
EU/1/09/606/011-012
Temozolomide Teva B.V.
Temozolomide Teva 5 mg hard capsules
EU/1/09/606/001-002
Temozolomide Teva B.V.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.